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Abstract
Background: The three bacteriophage genes gtrA, gtrB and gtr(type) are responsible for O-antigen glucosylation in
Shigella flexneri. Both gtrA and gtrB have been demonstrated to be highly conserved and interchangeable among
serotypes while gtr(type) was found to be specific to each serotype, leading to the hypothesis that the Gtr(type)
proteins are responsible for attaching glucosyl groups to the O-antigen in a site- and serotype- specific manner.
Based on the confirmed topologies of GtrI, GtrII and GtrV, such interaction and attachment of the glucosyl groups
to the O-antigen has been postulated to occur in the periplasm.
Results: In this study, the topology of GtrIV was experimentally determined by creating different fusions between
GtrIV and a dual-reporter protein, PhoA/LacZ. This study shows that GtrIV consists of 8 transmembrane helices, 2
large periplasmic loops, 2 small cytoplasmic N- and C- terminal ends and a re-entrant loop that occurs between
transmembrane helices III and IV. Though this topology differs from that of GtrI, GtrII, GtrV and GtrX, it is very
similar to that of GtrIc. Furthermore, both the N-terminal periplasmic and the C-terminal periplasmic loops are
important for GtrIV function as shown via a series of loop deletion experiments and the creation of chimeric
proteins between GtrIV and its closest structural homologue, GtrIc.
Conclusion: The current study provides the basis for elucidating the structure and mechanism of action of this
important O-antigen modifying glucosyltransferase.
Background
Shigellosis, or bacillary dysentery, is caused by members
of the genus Shigella. This genus belongs to the Gram-
negative bacterial family Enterobacteriaceae, and is
divided into 4 species: S. flexneri, S. dysenteriae, S. boy-
dii, and S. sonnei, all of which cause shigellosis. Shigella
flexneri, the species responsible for the highest mortality
rate, is endemic in most developing countries. There are
15 known S. flexneri serotypes, which differ in their
virulence, prevalence, distribution and O-antigens [1,2].
The O-antigen is the distal capping moiety of the
bacterial
lipopolysaccharide (LPS), a molecule that extends
from the bacterial surface. The O-antigen backbone
consists of repeating units of the tetrasaccharide N-acet-
ylglucosamine-rhamnose I-rhamnose II-rhamnose III
[3]. This basic backbone, serotype Y, is present in all
serotypes except serotype 6 and 6a. The addition of glu-
cosyl and/or O-acetyl groups to different sugars in the
tetrasaccharide unit by one of several linkages gives rise
to different serotypes. Glucosylation can occur in any
one of the four residues that are present in the tetrasac-
charide unit. O-acetylation was thought to occur only
on the rhamnose III residue, resulting in the group 6
epitope [4]. However, recent studies have revealed that a
degree of O-acetylation may be occurring on the other
sugars as well [5,6].
The three genes involved in O-antigen glucosylation
are gtrA, gtrB, and gtr(type). They are encoded by tempe-
rate bacteriophages and located downstream of the attP
site in the bacteriophage genome [2]. While gtrA and
gtrB, which encode for GtrA and GtrB, are highly con-
served and interchangeable among serotypes [7-10], gtr
(type) , which encodes for Gtr(type) protein, is serotype-
specific and is unique to each bacteriophage. It is
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hypothesised that GtrB catalyses the transfer of glucose
from UDP-glucose to bactoprenol phosphate to form
UndP-b-glucose in the cytoplasm [10]. This molecule is
then flipped by GtrA into the periplasm before the glu-
cosyl residue is attached by the Gtr(type) to the growing
O-antigen unit [11]. This attachment is thought to take
place in the periplasm. GtrIV adds a glucosyl residue to
N-acetylglucosamine of the O-antigen repeat unit via an
a1,6 linkage, thus converting serotype Y to serotype 4a.
In this study, a dual reporter system consisting of
alkaline phosphatase (phoA) which is in-frame with the
b-galactosidase a-fragment (lacZa) developed by Alex-
eyev and Winkler [12] was used to determine the mem-
brane topology of GtrIV. Alkaline phosphatase (AP) is
an E. coli enzyme that is only active when it is localised
in the periplasm as the mature part of PhoA is oxidised
such that the cysteine residues are able to form disulfide
bridges. This enables PhoA to fold correctly [12]. In
contrast to AP, b-galactosidase (BG) is only active in the
cytoplasm as the a-fragment must interact with the
cytoplasmically expressed w-fragment of the enzyme to
cause a-complementation [12].
Here we report that GtrIV clearly differs from the
topologies of the other Gtrs (GtrI, GtrII, GtrV, GtrX)
but is strikingly similar to the confirmed topology of
GtrIc, a newly discovered glucosyltransferase, which has
11 transmembrane regions, a short cytoplsmic C-term-
inal tail and two large periplasmic loops [13]. Based on
the fact that glucosylation is thought to occur in the
periplasm [10], we also show that the two large periplas-
mic loops of GtrIV are important for its stable assembly
in the membrane and function by creating GtrIV pro-
teins that have either the N-terminal periplasmic loop
or various segments of the C-terminal periplasmic loop
deleted, resulting in the abolishment of O-antigen modi-
fication from serotype Y to serotype 4a.
Methods
Growth conditions of bacterial strains
All bacterial cultures were grown aerobically at 37°C on
either liquid Luria-Bertani (LB) agar plates or in liquid
LB medium. Antibiotics such as chloramphenicol
(Sigma), kanamycin (Sigma) and ampicillin (Sigma) were
added to solid and liquid media when required. The
final concentrations of these antibiotics were 25 mg/mL,
50 mg/mL, and 100 mg/mL, respectively. Bacterial plates
were stored for up to 3 weeks at 4°C in the cold room.
The E. coli strains used in this study are derivatives of
E. coli K-12. XL1-Blue MRF’ E. coli was used for routine
cloning procedures while JM109 E. coli was used for
cloning of topology constructs to be screened on Dual
indicator (DI) plates that contain the chromogenic sub-
strates X-phos (5-bromo-4-chloroindol-3-inolyl phos-
phate disodium salt, Sigma) for alkaline phosphatase
and Red-Gal (6-chloroindol-3-inolyl-b-D-galactoside,
Research Organics) for b-galactosidase as outlined by
Alexeyev and Winkler [12].
DNA cloning techniques
All plasmids constructed in this study were derived from
the cloning vector pBC SK+ (Stratagene). They were
maintained in JM109 cells and isolated by means of
using either the QIAGEN MiniPrep Kit or the alkaline
lysis method adapted by Sambrook and Russell [14]
from Birnboim and Doly [15]. Restriction enzymes were
purchased from Fermentas or New England Biolabs
(NEB). Amplification of specific genes was performed
via PCR by using Pfu ultraII poymerase (Stratagene) and
specific oligonucleotide primers purchased from Sigma-
Aldrich (Additional file 1, Table S1). T4 DNA ligase
(Promega) was used for all ligation reactions as specified
by Promega. Electrocompetent cells for bacterial trans-
formations were prepared according to Dower et al. [16]
and transformations were carried out as described by
Sambrook and Russell [14] and Dower et al. [16]. DNA
sequencing was performed at the Biomolecular
Resources Facility, John Curtin School of Medical
Research, The Australian National University. Point
mutations within gtrIV were introduced using the Quik-
Change Site-Directed Mutagenesis Kit (Stratagene). The
resulting amplicon was then treated with DpnI before
being introduced into XL1-Blue MRF’ E. coli that repairs
nicks. The mutant constructs were sequenced to con-
firm the desired mutation.
Computer analysis of protein topology
Six topology prediction programs that were available
online were used to examine the GtrIV protein sequence
for the presence of hydrophobic regions. They were
HMMTOP [http://www.enzim.hu/hmmtop/] [17], SOSUI
[http://bp.nuap.nagoya-u.ac.jp/sosui/] [18], TMpred
[http://www.ch.embnet.org/software/TMPRED_form.
html] [19], DAS [http://www.sbc.su.se/~miklos/DAS/]
[20], TopPredII [http://bioweb.pasteur.fr/seqanal/inter-
faces/toppred.html] [21] and finally, TMHMM [http://
www.cbs.dtu.dk/services/TMHMM/] [22].
Creating a topology template and generation of
constructs for topology studies
Before exonuclease III (Exo III) deletion and PCR-based
fusions can be carried out to create gtrIV-phoA/lacZ trun-
cations, an appropriate template had to be created such
that gtrIV is in tandem with the phoA/lacZ dual reporter.
pNV1090, constructed by Korres and Verma [23], contains
gtrV in tandem with phoA/lacZ. The majority of
pNV1090, with the exception of gtrV, was amplified with
forward primer 1090XbaIFnew containing an XbaI site
that anneals directly upstream of phoA/lacZ in pNV1090
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and reverse primer 1090NheIRnew containing anNheI site
that anneals upstream of gtrV. Similarly, gtrIV was ampli-
fied from pNV739 (containing gtrIV) using a forward pri-
mer gtrIVNheIFnew (5’-TCAGCTAGCCTCGGTGG
TGTGCAGCTC-3’) and a reverse primer gtrIVXbaIRnew
(5’-TCATCTAGACCCCCCAGGATAACTGTGGG-3’).
Ligation of both amplicons created pNV1473 (Additional
file 2, Figure S1) which contains a PstI site closest to
phoA/lacZ that leaves an Exo III-resistant 3’ overhang and
a BamHI site closest to gtrIV that provides an Exo III-sus-
ceptible 5’ overhang. Upon creation of pNV1473, the plas-
mid was linearised by a PstI/BamHI double digestion and
progressively deleted from the end of gtrIV using the
Erase-a-base kit from Promega. PCR was also used to cre-
ate gtrVI-phoA/lacZ fusions. In this approach, the majority
of pNV1473 was amplified using the forward primer phoF
(5’- GTTCTGGAAAACCGGGCTGCTCAG-3’), which
anneals at the beginning of the phoA/lacZ sequence, and a
reverse primer that anneals at the point of interest in
gtrIV.
In order to make sandwich fusions, NruI sites were
first incorporated into the gtrIV sequence in pNV1473
via site-directed mutagenesis. NruI digest screening was
used to identify successfully mutated constructs and
they were tested for functionality by slide agglutination
(as described below). phoA/lacZ was excised from
pMA632 by either SmaI/EcoRV, EheI/Ecl136II or StuI/
NruI double digests, such that phoA/lacZ fragment
would be in-frame when ligated with the NruI digested
fragments. JM109 was transformed with the ligation
mixtures and plated onto DI plates. Colonies that dis-
played colouration were investigated further using
restriction digests and then verified by sequencing using
M13R or the PHOSEQNewR primers.
Quantifying alkaline phosphatase and b-galactosidase
activities
Alkaline phosphatase (AP) and b-galactosidase (BG)
assays were carried out to quantify the AP and BG
activities, respectively. Both assays were performed in
parallel with duplicates for each experiment. After
obtaining the AP and BG activities for each fusion in
the data set, the normalised activity ratios (NAR) were
calculated as follows [24,25]:
NAR = (Alkaline phosphatase activity/highest Alkaline
phosphatase activity)/(b-galactosidase activity/highest b-
galactosidase activity)
Functional analysis of GtrIV
The function of Gtr proteins were tested by transforma-
tion into SFL1616, a serotype Y Shigella strain contain-
ing chromosomally-encoded gtrA and gtrB. Serotype
conversion (from serotype Y to serotype 4a) indicated a
functional GtrIV protein. Slide agglutination assays were
carried out by bacteria grown to log phase at 37°C (A600
0.8-1.0), mixing the culture gently on a glass slide with
Type IV antisera (Denka Seiken) and observing for
agglutination [26].
Bacterial lipopolysaccharide (LPS) preparation
This method was adapted from Hitchcock and Brown
[27] with several modifications. Overnight cultures were
diluted 1/100 in LB containing the appropriate antibio-
tics and incubated for 2 - 3 h at 37°C until OD600 of 0.6
was reached. 1.5 ml of culture was then spun down and
the pellet was resuspended in 80 μl sample loading buf-
fer (4% SDS, 160 mM Tris-HCl, 20% glycerol, 10% b-
mercaptoethanol). Proteinase K was then added to each
sample at a concentration of 50 mg/ml and the samples
were incubated overnight at 56°C and stored at -20°C.
Before samples are run on 12% SDS-PAGE gel, 0.5 μl b-
mercaptoethanol was added to the samples and boiled
for 10 min.
Membrane protein preparation
The membrane protein isolation method is a modified
version of that described by Morona et al. [28]. Cells
were grown in LB to mid-log (OD600 of 0.6) and pel-
leted using a Sorvall SLA1500 rotor (7,000 rpm, 10 min,
4°C) and resuspended in 1 ml of 20% (w/v) sucrose, 30
mM Tris-HCl pH 8.1, transferred to SS-34 tubes and
chilled on ice. 0.1 ml of 1 mg/ml lysozyme in 0.1 M
EDTA pH 7.3 was added to the cells for 30 min on ice.
The cells were collected again as described above using
a Sorvall SS-34 rotor and the pellet frozen for 30 min at
-80°C. The pellet was thawed and resuspended vigor-
ously in 6 ml 3 mM EDTA, pH 7.3. The cells were com-
pletely lysed by passing them twice through a French
Press at 15,000 psi. Unlysed cells and inclusion bodies
were removed by slow centrifugation as described above
(7,000 rpm, 10 min, 4°C). Membrane proteins were sedi-
mented by high speed centrifugation using a 50Ti or
80Ti rotor spun at 35, 000 rpm for 90 min at 4°C. The
pellet was then resuspended in 200 μl sterile Milli Q
H2O.
Western blotting of proteins
Western blotting was carried out as described by
Thanweer et al [29]. For membrane preparations 10 μl
of each 2 mg/ml sample was loaded and for LPS sam-
ples, 10 μl of each LPS extraction was loaded. Primary
antibodies used were either Mouse anti-alkaline phos-
phatase (Chemicon) diluted 1:1000 for membrane pro-
tein preparations, Type IV antisera (Denka Seiken)
diluted 1:100 or serotype Ic-specific MASFIc monoclo-
nal antibody (Reagensia) diluted 1:500 for bacterial LPS
extractions. The secondary antibodies used were Goat
anti-mouse IgG horse radish peroxidase (HRP)-
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conjugated (Sigma) diluted 1:8000 for membrane protein
preparations while Goat anti-rabbit HRP-conjugated Ig
(Sigma) diluted 1:1000 and anti-mouse IgM peroxidise
conjugate (Sigma) diluted 1:5000 were used for profiling
bacterial LPS extraction. The reactions were detected
either by X-ray film (GE Healthcare) or viewed under
the Fusion Chemiluminescence Camera (Fisher Biotech).
Results and discussion
Determination of GtrIV topology
A predicted topology model for GtrIV was created based
on the results given by the various web-based prediction
programs (Additional file 1, Table S2). There was no
common prediction amongst the programs. HMMTOP
and TMPred both predicted that GtrIV has 8 trans-
membrane helices. TopPred and TMHMM predicted 9
transmembrane helices while SOSUI and DAS predicted
10 transmembrane helices and 11 transmembrane
helices, respectively. Of all the programs, HMMTOP
and TMHMM both predicted that the N-terminus was
cytoplasmic. TopPred predicted that the N-terminus
was in the periplasm while the rest of the programs did
not provide any information about the localisation of
the N-terminus. From the information that has been
gathered from the confirmed topologies of GtrI, GtrII
and GtrV, a large periplasmic C-terminal tail was
expected. By collating the data from all the programs, a
consensus model was created. In this model, GtrIV is
shown to have 10 transmembrane helices, a cytoplasmic
N-terminus, a small cytoplasmic C-terminal region, and
two large periplasmic loops between transmembrane
helices I and II, and transmembrane helices VII and
VIII (Additional file 3, Figure S2).
To experimentally verify this hypothetical GtrIV
model, three different fusion approaches were used. The
nested deletion system, which utilised exonuclease III
(Exo III) deletion from the end of the gtrIV gene fol-
lowed by fusion with phoA/lacZ, resulted in about 200
coloured colonies on DI plates. Subsequent screening of
these colonies and sequence analysis yielded 19 unique
in-frame GtrIV/PhoA-LacZ fusion proteins. The col-
ourations displayed by these 19 fusions were in agree-
ment with the topology model. A blue colouration,
which is caused by the breakdown of X-phos by PhoA,
indicated a periplasmic localisation. Likewise, LacZ
breakdown of Red-Gal yielded a red colouration, indica-
tive of a cytoplasmic localisation. A purple colouration,
on the other hand, indicated that the fusion was within
the transmembrane helix as a combination of both red
and blue colouration is present, thus giving the colony
its purple appearance. To further check if these fusions
are in agreement with the model, alkaline phosphatase
activity (AP) and b-galactosidase (BG) activity for these
19 in-frame fusions were measured via enzyme assays
for AP and BG activity and the Normalised Activity
Ratios (NARs) were calculated. Table 1 shows the NAR
values. The NAR values were generally consistent with
the previously observed coloured colonies. Interestingly,
only one in-frame red fusion was obtained by Exo III
deletion. Most of the Exo III mediated fusions were
seen to occur in the two large putative periplasmic
loops. Given that the consensus model shows that all
the cytoplasmic loops are relatively small, there will only
be a smaller chance of an in-frame fusion occurring
within these loops. According to Alexeyev and Winkler
[30], NARs greater than 2:1 or lower than 1:2 indicate
that at least 67% of the reporter activity is properly loca-
lised. Alexeyev and Winkler [12] also stated that the
reliability of NARs in providing data about reporter
membrane localization is related to the size and diver-
sity of the set of fusions and can be tested by choosing
the second highest reference point in calculating the
NARs. This was performed (results not shown), and the
NARs remained consistent with the previously deter-
mined localization of the reporter thus fortifying our
confidence in the finalized topology of GtrIV. All the
computer programs did not give the same results and
therefore, this highlights the importance of verifying the
computer based consensus model. Fusion I200 reported
a red DI colouration and a NAR of 1:34. Although this
is evidence of cytoplasmic localisation, it showed a high
AP activity of 22. Seeing as it also had a substantially
high BG activity of 132, it suggests that this fusion is in
agreement with the topology model and located in close
proximity to the cytoplasmic face of transmembrane
helix IV. Alexeyev and Winkler [12], state that purple
fusions result as an association of the fusion to a trans-
membrane region. This is not an exclusive rule, as seen
with fusion I200. The red DI colouration could be a
result of the fusion’s overwhelmingly higher BG activity
coming to the fore. A total of 4 purple fusions were
obtained from Exo III deletion. Fusions A15, Q186,
V359 and Q393 have NAR values of 2:1, 1:11, 5:1 and
1:4, respectively. Fusion V359 shows periplasmic locali-
sation while fusions Q186 and Q393 show cytoplasmic
localisation. Though their NAR values suggest that these
fusions are either localised in the periplasm or cyto-
plasm, it can be seen in Table 1 that among these four
fusions, the lowest average AP activity is 9 while the
lowest average BG activity is 8. This therefore indicates
that some level AP and BG activity is present in these
fusions. The varying NAR values obtained is attributed
to the fact that the %AP values are obtained using high-
est AP activity of 976, while the %BG values are
obtained using the highest BG activity of 155.
The topology of GtrIV was further elucidated by using
two more strategies. These include a PCR-based
approach and the use of sandwich fusions. Using the
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PCR-based fusion technique, it allowed us to exactly
fuse the dual reporter to predetermined points in the
protein. The second method involved the construction
of sandwich fusions. A sandwich fusion can indicate a
more accurate representation of topology since the
whole protein is present with the dual reporter sand-
wiched in the middle. These two methods generated a
host of constructs. Fusions D146, D406 and K438 were
obtained via PCR based fusions. R93, K117, A181 and
R375 were generated using gtrIV/phoA-lacZ/gtrIV
sandwich fusions. A NAR value of 1: > 100 for the PCR-
constructed red fusion K438 confirms that the C-term-
inal end is cytoplasmic. Fusion D406 with a NAR value
of 20:1 indicated that loop No. 10 is in the periplasm.
While both these fusions satisfied the consensus model,
D146 was observed to display blue colouration with a
NAR value of 21:1. This fusion was in contradiction to
the hypothetical model, which predicts D146 to be loca-
lised in the cytoplasm between transmebrane helices IV
and V. Sandwich fusion K117 displayed a NAR value of
Table 1 Analysis of gtrIV-phoA/lacZ fusions and gtrIV-phoA/lacZ-gtrIV sandwich fusions for GtrIV topology
determination
Sample ID AA1 Colour2 Average AP3 Average BG4 %AP5 %BG6 NAR7
(AP:BG)
Location on Model8
Random C-terminal Fusions
B1925 A15 Purple 311 ± 9 25 ± 2 32.6% 16.1% 2:1 t.1
B1910 N29 Blue 356 ± 47 1# 37.3% 0.6% 52:1 p.2
B1924 P38 Blue 357 ± 44 2# 37.5% 1.3% 24:1 p.2
B1907 N41 Blue 296 ± 47 1# 31.1% 0.6% 38:1 p.2
B1935 G42 Blue 195 ± 28 3 ± 1 20.5% 1.3% 20:1 p.2
B1906 L56 Blue 133 ± 29 4 ± 1 14.0% 2.6% 5:1 p.2
B1931 F60 Blue 383 ± 25 1# 40.2% 0.6% 57:1 p.2
B1912 Q186 Purple 9 ± 91 15 ± 2 0.9% 9.7% 1:11 t.4
B1919 I200 Red 22 ± 4 132 ± 6 2.3% 85.1% 1:34 t.4
B1913 N235 Blue 292 ± 51 0# 30.6% 0.0% > 100:1 p.6
B1926 L240 Blue 394 ± 20 1# 41.4% 0.7% 58:1 p.6
B1904 L246 Blue 660 ± 39 1# 69.3% 0.7% 97:1 p.6
B1921 N251 Blue 962* ± 59 1# 100.9% 0.9% > 100:1 p.6
B1922 N255 Blue 553 ± 30 0# 58.1% 0.1% > 100:1 p.6
B1908 D261 Blue 385 ± 55 2# 40.4% 1.2% 33:1 p.6
B1905 S300 Blue 426 ± 21 4 ± 1 43.6% 2.8% 16:1 p.6
B1923 M310 Blue 589 ± 15 1 ± 1 61.8% 0.1% > 100:1 p.6
B1920 V359 Purple 269 ± 34 9 ± 1 28.2% 5.5% 5:1 t.6
B1911 Q393 Purple 12 ± 3 8 ± 2 1.2% 4.9% 1:4 t.7
PCR-Constructed Fusions
B2216 V102 Red 2# 121 ± 17 0.2% 78.2% 1: > 100 c.3
B1937 D146 Blue 953 ± 35 7 ± 1 100.0% 4.3% 23:1 re (p.4)
B2217 V155 Red 6 ± 2 71 ± 9 0.6% 45.8% 1:76 re (c.4)
B2405 K162 Red 5# 11# 0.5% 7.1% 1:14 re (c.4)
B2225 D169 Red 3# 79 ± 17 0.3% 51.1% 1: > 100 re (c.4)
B1936 D406 Blue 177 ± 40 1# 18.6% 0.9% 20:1 p.8
B1914 K437 Red 5 ± 1 155** ± 8 0.5% 100.0% 1: > 100 c.9
Sandwich Fusions
B2187 R93 Red 0# 10 ± 2 0.1% 21.3% 1: > 100 c.3
B2190 K117 Red 0# 14 ± 2 0.3% 29.4% 1: > 100 c.3
B2143 A181 Blue 135+ ± 25 0# 100.0% 0.3% > 100:1 re (p.4)
B2192 R375 Red 1 ± 1 47++ ± 7 0.4% 100.0% 1: > 100 c.7
1 Position of the last residue of GtrIV followed by phoA/lacZ, 2 Colour of colony as seen on dual indicator plates, 3,4 Activities of the fusions, average of four
independent experiments with standard deviations of each activity, 5,6 Percentages of AP and BG activities measured relative to the maximum activity in the set,
7Normalised AP:BG activity ratio (NAR) rounded to the nearest integer. 8Location of the fusion on the adjusted topological model of GtrIV(Figure 1); c, cytoplasm;
p, periplasm; t, transmembrane helix; re, re-entrant loop. *Highest truncation AP, **Highest truncation BG, +Highest Sandwich fusion AP, ++Highest sandwich
fusion BG. Since the random C-terminal fusions and PCR mediated fusions brought about truncated protein fused to the dual reporter, they were taken as one
data set and the highest respective AP and BG values between them was used to calculate the NAR values. The NAR values for the sandwich fusions were
calculated separately based on the highest AP and BG values obtained from all the sandwich fusions alone. #Standard deviations were less than 0.5 and not
included.
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1: > 100 that corresponded with its red colouration and
confirms its localisation to the cytoplasm.
TMpred and HMMTOP topology programs predicted
similar models in which K117 was predicted to be in
the cytoplasm and D146 was predicted to be in the peri-
plasm. Truncation fusion V102 which reported a red
colouration on DI plates and a high BG NAR compared
to AP, strongly suggests that GtrIV had a cytoplasmic
loop between transmembrane helices II and III. This
fusion was in between both sandwich fusions R93 and
K117 that displayed NAR values and colouration favour-
ing a higher BG ratio to AP and a cytoplasmic localisa-
tion. According to these results, the model was modified
accordingly such that transmembrane helix III from the
consensus mode (Additional file 3, Figure S2) was
pushed into the cytoplasm along with periplasmic loop
No. 4. This consequently would invert transmembrane
helix IV, thus allowing the consensus loop No. 5 (con-
taining D146) to be localised in the periplasm. However,
inverting loop No. 5 into the periplasm also meant that
a large periplasmic loop between the modified trans-
membrane helices III and IV spanning 47 amino acids
was created by including transmembrane helix V of the
consensus model. To support this theory, truncation
fusions V155 and D169 were then designed so that they
were evenly spaced between D146 and A181, to verify
the newly modelled periplasmic loop. Both fusions dis-
played red colouration and NAR values of high BG to
AP ratios. In order to satisfy the current results, a re-
entrant loop was introduced in the proposed model that
completely traverses the plasma membrane into the
cytoplasm and loops back up into the periplasm such
that V155 and D169 are both localised in the cytoplasm.
Analysis of the TMS prediction algorithms indicated
that throughout the protein sequence, the transmem-
rane helices were predicted as clear hydrophobic peaks.
However, between amino acid regions P140-I187, two
double peaks exist which can be deduced as transmem-
brane regions (Additional file 4, Figure S3). This trend
was also witnessed for the topology prediction of GtrIc
[13]. The finalised membrane topology of GtrIV is
shown in Figure 1. The blue fusions obtained via Exo III
deletions confirmed the periplasmic locations of loop
No. 2 and loop No. 6, while blue truncation fusion
D406 confirmed that loop No. 8 is in the periplasm.
The presence of two large periplasmic loops gives
weight to the hypothesis that glucosylation takes place
in the periplasm. Therefore, these two loops provide
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Figure 1 The final GtrIV topology model. Final GtrIV topology model after the creation of gtrIV-phoA/lacZ fusions by the Exo III deletion and
PCR-based approaches, and gtrIV-phoA/lacZ-gtrIV sandwich fusions. In this model, GtrIV is shown to have 8 transmembrane helices and two large
periplasmic loops. All Exo III mediated fusions are indicated with the closed circles while PCR mediated fusions are indicated with the crosses. All
sandwich fusions are indicated with the stars. Blue coloured stars, circles and crosses depict fusions that have high PhoA NARs and appear blue
on DI plates. Similarly, the ones in red depict fusions that have high LacZ NARs and appear red on DI plates. All purple fusions are seen to have
occurred within transmembrane helices. The proposed re-entrant loop which traverses the plasma membrane from the periplasm into the
cytoplasm, forming a cytoplasmic loop, occurs between transmembrane helices III and IV. All fusions have been labelled with the residue at
which the fusion with PhoA/LacZ takes place or, in the case of sandwich fusions, where the dual reporter protein has been inserted.
Nair et al. BMC Biochemistry 2011, 12:67
http://www.biomedcentral.com/1471-2091/12/67
Page 6 of 14
excellent candidates for GtrIV functional studies. Red
fusions I200 and K438 confirm the cytoplasmic localiza-
tion of loop No. 5 and the C-terminus of GtrI, respec-
tively. Sandwich fusion R375 confirms the cytoplasmic
loop No. 7, while sandwich fusions R93 and K117 along
with truncation fusion V102 show that loop No. 3 of
GtrIV is indeed a large cytoplasmic loop, uncharacteris-
tic to the other Gtrs. Such a large cytoplasmic loop is
known to exist in another protein involved in S. flexneri
O-antigen acetylation, O-acetyltransferase (Oac) [29].
Since glucosylation of the O-antigen is thought to occur
in the periplasm, it may play a part in helping to main-
tain the structural integrity of GtrIV during the glucosy-
lation process. Blue fusions D146 and A181, together
with red fusions V155 and D169 suggest the presence of
a re-entrant loop between the amino acid regions P140
- I187 that starts from the periplasm and traverses
through the plasma membrane into the cytoplasm,
forming an intramembrane dipping segment which then
traverses back into the periplasm. This unique re-
entrant loop structure was put forward following com-
parisons with GtrIc, the closest structural homologue of
GtrIV and is hypothesised to provide structural flexibil-
ity in order to facilitate interaction between periplasmic
loop No. 2 and periplasmic loop No. 6. As mentioned
before, GtrIc has an almost identical topology to that of
GtrIV. Ramiscal et al [13] have also shown that a Gtr-
conserved re-entrant loop exists at the lateral centre of
GtrIc, between transmembrane helices IV and V. Unlike
the re-entrant loops seen in GtrII and GtrV [23,31],
Ramiscal et al [13] proposed that it formed a double
intramembrane dipping region which can be defined as
a protein segment that does not completely penetrate
the bilayer but briefly enters and exits the same mem-
brane face [32]. In light of the current results and con-
sidering that GtrIc is the closest homologue to GtrIV,
an intramembrane dipping region seems to exist in
GtrIV between residues V155 and D169. As this region
is rich in isoleucines (hydrophobic residue), it further
supports the presence of such an intramembrane dip-
ping region. However, the presence of a KKE tract
within this region could also point to a cytoplasmic
loop. Therefore, to reinforce this, a final truncation
fusion was designed at K162. This fusion reported a red
DI colouration and NAR of 1:14. The relatively low
NAR value and BG activity of K162 (11) suggests that
while in the cytoplasm, this loop might be folded such
that it is close to the plasma membrane. There is a pos-
sibility of the presence of an intramembrane dipping
region occurring within V155 and D169. In this case,
the reported red colouration and subsequent BG enzy-
matic function may have resulted from the effect of
PhoA/LacZ weighing down the region such that it is
pulled back into the cytoplasm. This could account for
its low BG activity as compared to V155 and D169.
However, without the use of visual technology such as
X-ray crystallography, such structures are difficult to
prove. Hence, we propose the presence of a re-entrant
loop between transmembrane helices III and IV of
GtrIV, which starts at the periplasmic face of the protein
and traverses down into the cytoplasm before making its
way back to the periplasm. Re-entrant loops have been
documented in eukaryotic glutamate transporters [33],
in the bacterial potassium channel KcsA [34] and in var-
ious other channels as reviewed by Harris-Warrick [35].
This proposed re-entrant loop may be of minimal influ-
ence on catalytic potential but may instead provide
GtrIV with the conformational flexibility required to
transfer a glucosyl group from a membrane lipid to the
O-antigen, as proposed by Korres and Verma [23] for
the GtrV protein.
Identifying regions critical for GtrIV function
By identifying critical regions of a protein, it helps pro-
vide an insight and may also uncover vital clues to help
elucidate its mechanism of action. Residues that are cri-
tical within these regions may not only be involved
directly in catalysis but also in interacting with sub-
strates and other proteins in a complex. These residues
may also be responsible for maintaining the structural
integrity of the protein in assisting other critical residues
to form the catalytic site [30]. Multiple alignments of
both the large periplasmic loops of GtrIV were carried
out against the other Gtrs. Although it was found that
there was a low level of homology between the periplas-
mic loops, with the exception of some acidic residues in
periplasmic loop No. 2, GtrIV loop No. 2 shares struc-
tural homology with the loop No. 2 of other Gtrs
[13,23,31,36]. Therefore, it is proposed that periplasmic
loop No. 2 in all Gtrs may perform the conserved func-
tion of interacting with the UndP-Glucose and possibly
recycling the lipid carrier back to the cytoplasmic face
of the membrane. To prove the importance of GtrIV
loop No. 2 in such function, it was deleted via PCR by
using specific forward and reverse primers as outlined
in Table S1 (Figure 2). The template DNA used for this
deletion PCR was fusion K438 (C-terminal fused to
PhoA/LacZ dual reporter protein) obtained during
topology studies. This construct was chosen since it can
be detected on a Western blot using anti-alkaline phos-
phatase antibodies to determine expression and assem-
bly in the membrane. Though loop No. 2 is
topologically homologous to all Gtrs, GtrIV also has a
unique cytoplasmic loop No. 3 consisting of 30 amino
acids. Considering that glucosylation occurs in the peri-
plasm, the presence of this large cytoplasmic loop is
unusual as it is not seen in the other Gtrs. This drew
our attention and we proceeded to create a loop No. 3
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deletion to investigate its role in the function of GtrIV
(Figure 2). This deletion mutant was created via PCR
using specific reverse and forward primers (Additional
file 1, Table S1) by utilising the same template that used
in creating the loop No. 2 deletion.
Loop No. 6 of GtrIV was found to contain 8 aspartic
acid residues and 7 glutamic acid residues (15 negatively
charged acidic residues in total) spread throughout the
loop (Figure 2), and is hypothesised to be responsible
for adding a glucosyl residue to the N-acetylglucosamine
of the O-antigen repeat unit via an a1,6 linkage, thus
converting serotype Y to serotype 4a. Korres and Verma
[36] have suggested that the acidic residue D380 in
GtrV is important for GtrV function because it is
believed to interact with the O-antigen to stabilise it so
that the glucosyl residue can come in contact with the
correct rhamnose. Based on this hypothesis, any one or
a combination of the 15 acidic residues may perform
this stabilising function in GtrIV. It is also distinctly
possible that these acidic residues compensate for the
loss of the other acidic residues which would explain
why there are three sets of paired acidic residues flanked
on either side by a different acidic reside situated 7-9
residues away. To investigate this, a series of loop No. 6
deletions that targeted each set of paired acidic residues
together with the flanking acidic residues were con-
structed (Figure 2). Specific forward and reverse primers
were used to amplify the majority of the plasmid, which
contains GtrIV which already has PhoA/LacZ fused to
its C-terminal (pNV1532) except for the loop segments
to be deleted. Positive clones were screened by SmaI
digest and confirmed by sequencing. A total of 4 clones
were constructed with various deletions in loop No. 6.
Loop No. 6 deletion, loop No. 6 partial deletions 1, 2
and 3 (Figure 2) were obtained and transformed into
SFL1616 (serotype Y) for functionality testing using
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three negatively charged amino acid pairs DE261, ED283 and ED326. Deletion experiments for loop No. 2 involved deleting all the residues
highlighted in brown, while a deletion in loop No. 3 was brought about by deleting all the residues highlighted in red. In loop No. 6, 4 different
loop deletions were created. To investigate the importance of the negatively charged residues, all residues between the two black lines, which
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were deleted separately.
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Type IV antisera. The results of all deletions were nega-
tive in a slide agglutination test using Type IV antisera
(Figure 3a). Although slide agglutination tests are accu-
rate, there is a possibility that the deletions have caused
a decrease in function of the protein. In such a scenario,
the agglutination effect would be quite difficult to visua-
lise. To overcome this effect, Western immunoblots
using Type IV antisera were performed on bacterial LPS
extracted from the deletion mutants to confirm the slide
agglutination results (Figure 3a). The results of the LPS
immunoblots also showed that all the deletions were
unable to convert serotype Y to serotype 4a. Deletion of
such large segments of protein may result in protein
misfolding. This would in turn abolish GtrIV function.
As GtrIV is transmembrane protein, such misfolding
would result in reduced protein assembly in the bacter-
ial membrane. To investigate this, we then carried out
Western immunoblots on the membrane protein
extracts of the various loop deletion constructs to deter-
mine whether the deletions had any effect on protein
assembly in the membrane using anti-alkaline phospha-
tise antibodies (Figure 3b). If the deletions had an effect
on protein folding, then the misfolded GtrIV deletion
mutant might not be assembled on the membrane. Sub-
sequently, this would affect its ability to modify the O-
antigen. The Western blot results show that GtrIV was
not localised in the cellular membrane when loop No. 2
or loop No. 3 was deleted indicating that these loops
are essential for protein structure and assembly. The
results also showed that the deletion of loop No. 6 of
GtrIV and two of the three partial deletions reduced the
amount of protein that was assembled in the bacterial
membrane as compared to the fully intact protein. In
B2351, the amount of GtrIV that was present in the cel-
lular membrane was almost as high as the amount of
the intact GtrIV. This, coupled with the loss of func-
tionality of the deleted protein, provides us with an
insight that the missing 19 amino acid segment of loop
No. 6 partial deletion 3 could contain residues that may
be part of a catalytic site present in the large periplasmic
loop No. 6.
Four new deletion constructs that specifically targeted
the 19 amino acid spanning region were created (Figure
4a). The strategy used to create these new deletion con-
structs was identical to the one used in creating the pre-
vious loop No. 6 deletion constructs. Resulting clones
were screened via SmaI digests and confirmed by
sequencing. A total of 4 constructs (FD1, 2, 3 and 4)
were obtained and used to transform SFL1616. Func-
tional analysis of GtrIV deletion constructs through
slide agglutination and LPS Western blots revealed that
the introduced deletions FD1 and FD2 were tolerated
a)
Ͳve+ve ͲveͲveͲveͲveͲveͲve
b)
~108kDa
Figure 3 Functional analysis of deletion constructs. a) LPS Western blots and slide agglutination results. Deletion constructs were
transformed into a serotype Y strain (SFL1616) to test for modification of O-antigen to serotype 4a. SFL 2324 is GtrIV fused to PhoA/LacZ and
then transformed into SFL1616. The bright band is indicative of the serotype conversion from serotype Y to serotype 4a. The rest of the
deletions show absence of modification to serotype 4a when probed with Type IV antisera. Results of the slide agglutination assays are indicated
below the Western blots. A score of +ve indicates a positive result while a score of -ve indicates a negative result. b) Western blots (using anti-
alkaline phosphatase primary antibody) performed on the membrane protein extractions of the various GtrIV loop deletion constructs that were
fused to alkaline phosphatase. B2347 and B2348 were not detected, indicating GtrIV Loop No. 2 and Loop No. 3 deletions have a direct effect on
the assembly of the protein in the cellular membrane. B2349, B2350 and B2352 were detected in lower amounts, the amount of protein that is
assembled in the cellular membrane in these three deletion mutants is much lower as compared to the fully intact protein (B2339). The intense
band seen for B2351 is almost the same as the fully intact protein.
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whereas the deletions present in FD3 and FD4 knocked
out GtrIV function (Figure 4b). Western blots of the
membrane proteins extracted from these constructs
show that all the four further deletion proteins were
localised in the membrane (Figure 4c). This is in agree-
ment with the hypothesis that the missing segments
may be part of a catalytic site present in the large peri-
plasmic loop No. 6 that might be responsible for inter-
action with the glucosyl residue to be attached to the
O-antigen, but also with potential interactions between
GtrIV, GtrA and GtrB
Investigating periplasmic loop function of GtrIV by using
chimeric proteins
As previous studies on other Gtr(type) proteins have
shown that a degree functional similarity exists between
the Gtr(type) family, we sought to investigate the role of
loop No. 2 of GtrIV by creating chimeric proteins with
its closest structural homologue GtrIc. The accepted
dogma is that topologically similar N-terminal periplas-
mic loops in all Gtr(type) proteins may perform the con-
served functions of interacting with the UndP-glucose
and possibly recycling it to the cytoplasmic face. Thus,
if both the N-terminal periplasmic loops No. 2 of GtrIV
and GtrIc play the same role in O-antigen modification,
then swapping these two loops with each other should
not abolish function of the native proteins. Chimeric
proteins were created via a PCR-based approach, by
swapping the N-terminal periplasmic loops of GtrIV
and GtrIc to produce chimeric constructs (Table 2). The
templates chosen for both GtrIV and GtrIc contained
the PhoA/LacZ dual reporter fused to the C-terminal of
each protein. Functional analysis of these chimeric pro-
teins were carried out via slide agglutination and LPS
a)
b)
c)
~108kDa
NGKENPSWAVDECIGVDAW
-----PSWAVDECIGVDAW
NGKEN-----DECIGVDAW
NGKENPSWAV-----VDAW
NGKENPSWAVDECIG----
GtrIV :
GtrIV FD1 :
GtrIV FD2 :
GtrIV FD3 :
GtrIV FD4 :
251                                                  269
251                                                  269
251                                                  269
251                                                  269
251                                                  269
Figure 4 Further deletions of GtrIV loop No. 6. a) The sequence of the 19 amino acids located in GtrIV loop No. 6, which were targeted for
further deletion. The dashes in the sequences of GtrIV FD1, FD2, FD3 and FD4 indicate the amino acids that were deleted in each deletion set.
Amino acid numbers corresponding to the start and end of the peptide sequence are given below their respective residue. b) LPS Western blots
of GtrIV deletion constructs that were transformed into SFL1616 (Serotype Y). Deletion constructs FD1(SFL2331) and FD2 (SFL2332) were able to
convert serotype Y to serotype 4a, thus indicating functionality. The absence of bands for FD3 and FD4 indicates loss of function for these
deletion mutants. c) Western blots of GtrIV Loop No. 6 further deletion constructs. All the further deletion constructs were detected when the
membrane extracts were probed with anti-alkaline phosphatase. This indicated that the deletion proteins (which are fused to PhoA/LacZ) are
expressed.
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Table 2 Predicted structures of the four chimeric proteins created in this study between GtrIc and GtrIV
Chimera Constructs Slide Agglutination Western blots
LPS Membrane
MASF Ic Type IV MASF Ic Type IV Anti-PhoA
+ve -ve +ve -ve +ve
-ve +ve -ve +ve +ve
-ve -ve -ve -ve -ve
-ve -ve -ve -ve +ve
-ve -ve -ve -ve +ve
-ve -ve -ve -ve +ve
Points of fusion: a) GtrIc-GtrIV loop No.2-GtrIc chimera:GtrIc-F31/GtrIV-N27, GtrIV-Y68/GtrIc-V100, b) GtrIV-GtrIc loop No.2-GtrIV chimera: GtrIV-M26/GtrIc-H32, GtrIc-
N99/GtrIV-S71, c) GtrIc-GtrIV loop No.6-GtrIc chimera: GtrIc-P382/GtrIV-T231, GtrIV-K351/GtrIc-V495, d) GtrIV-GtrIc loop No.10-GtrIV chimera: GtrIV-S229/GtrIc-T231,
GtrIc-V381/GtrIV-D352. To test for GtrIc function, the chimera constructs were transformed in to SFL1416 (Serotype 1a) to test for serotype conversion to serotype
1c using MASF Ic. As for GtrIV function, conversion to serotype 4a was tested by using Type IV antisera against constructs that were transformed into SFL1616
(serotype Y). All membrane protein westerns were carried using anti-alkaline phosphatse antibodies.
Nair et al. BMC Biochemistry 2011, 12:67
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Western blotting using Type IV antisera and MASF Ic
as the primary antibodies to detect serotype conversion
to serotype 4a and serotype Ic, respectively (Table 2).
The hybrid GtrIc construct containing loop No. 2 of
GtrIc failed to convert serotype Y to serotype 4a. Simi-
larly, the hybrid GtrIc construct containing loop No. 2
of GtrIV was unable to convert serotype 1a to serotype
1c. This indicates that although loop No. 2 is topologi-
cally conserved, its low sequence identity cannot neces-
sarily establish a functional protein as observed in the
GtrV-GtrX Loop No. 2-GtrV chimera [36]. In retro-
spect, it is possible that the loop No. 2 of both proteins
may contain unique amino acid residues that are critical
for its conserved interaction with the UndP-Glucose
precursor, owing to the fact that the active sites for
both these proteins might require slightly different ter-
tiary structures in order to interact specifically with the
O-antigen.
In parallel to investigating the role of GtrIV loop No.
2, we also investigated the role of the C-terminal peri-
plasmic loop No. 6 of GtrIV. Gtrs I, II, V and × have
long periplasmic C-terminal ends that have been
hypothesised to be responsible for conferring serotype
specificity. In contrast, as both GtrIV and GtrIc have
short cytoplasmic C-terminal ends, their specific func-
tion is thought to be performed by the large periplasmic
loops No. 6 and No. 10 for GtrIV and GtrIc, respec-
tively. By using the same PCR-based approach for the
creation of the loop No. 2 chimeras, loop No. 6 of
GtrIV was replaced by loop No. 10 of GtrIc and vice
versa (Table 2). It was postulated that the hybrid GtrIV
containing loop No. 10 of GtrIc would be able to con-
vert serotype 1a to serotype 1c while the GtrIc-GtrIV
loop No. 6-GtrIc chimera would be able to convert sero-
type Y to serotype 4a. Slide agglutination and LPS Wes-
tern blots revealed absence of modification to respective
serotypes. As both large periplasmic loops contain over
100 amino acids each (123 amino acids in loop No. 6 of
GtrIV and 120 amino acids in loop No. 10 of GtrIc),
each loop can possibly accommodate its own unique
tertiary structure that would contribute to the serotype
specificity of O-antigen modification. Therefore, in
absence of this, GtrIV and GtrIc would not be able to
carry out their specific functions. Alternatively, the
structural integrity of each chimeric protein may have
been compromised with the addition of the foreign
loop. To confirm for assembly in the membrane, Wes-
tern blots (using anti-alkaline phosphatase antibodies)
were carried out on the membrane protein extracts of
each chimeric protein (Table 2). Of the four chimeric
proteins created, only GtrIc-GtrIV loop No. 2-GtrIc chi-
mera was not detected by the blot. Its non-functional
hybrid GtrIV counterpart however, was shown to have
been assembled in the membrane strongly implying that
specific interactions between residues present in its
native loop No. 2 are required to form a catalytic site
that facilitates O-antigen modification. The absence of
assembly in the bacterial membrane of the GtrIc-GtrIV
loop No. 2-GtrIc chimera suggests that GtrIV loop No.
2 has compromised the structural integrity of the GtrIc
protein. Similarly, loss of function for GtrIc-GtrIV loop
No. 6-GtrIc and GtrIV-GtrIc loop No. 10-GtrIV chi-
meras can be attributed to the importance of the two C-
terminal periplasmic loops in conferring serotype speci-
ficity through the addition of glucosyl residues to the O-
antigen in a site and linkage specific manner. As both
loops span more than 100 amino acids each, this would
facilitate intra-loop and inter-loop interactions that may
contribute to serotype specificity and O-antigen
modification.
The present study provides experimental evidence that
GtrIV shares structural similarities with GtrIc, thus dif-
fering from the rest of the Gtrs. Further studies using
site directed mutagenesis of amino acids between D260
to W269 and use of structure definition techniques
should allow us to identify critical residues and further
define the overall structure which will provide us with
critical information to better understand its mechanism
of action and catalytic site.
Conclusion
The structural similarity between GtrIV and GtrIc has
been shown in this study by confirming the presence of
a periplasmic loop No. 2, a large periplasmic loop No. 6
and a short cytoplasmic C-terminal end in GtrIV. The
existence of a re-entrant loop, similar to that seen in
GtrIc has also been observed. Two periplasmic regions
were identified that could be involved in the attachment
of the glucosyl group to the O-antigen. The non-critical
nature of the conserved acidic residues coupled by the
structural difference of GtrIV compared to the other
Gtrs, except GtrIc, could indicate that its mechanism of
action may be different from the rest of the Gtrs and
may be similar to that of GtrIc. By sequentially deleting
loop segments in loop No. 6, the presence of a potential
catalytic site located between residues D260 to W269
was hypothesised. To further investigate the roles of
conserved or specific functions of the two periplasmic
loops of GtrIV, loop swap experiments between the N-
terminal periplasmic loops and the C-terminal periplas-
mic loops were undertaken. The resulting hybrids lost
their native function and were unable to substitute func-
tion to the other protein. This signifies the importance
of both loops in GtrIV function. Furthermore, the iden-
tification of critical residues in these regions and further
structural studies will provide the basis for the localiza-
tion of the active site and the elucidation into the
mechanism of action of GtrIV.
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Additional material
Additional file 1: Tables S1 and S2. List of Primers used and Results
from the computer programs used to predict GtrIV topology and the
basis for each prediction.
Additional file 2: Figure S1. The structure of pNV1473 depicting gtrIV
and phoA/lacZ in tandem.
Additional file 3: Figure S2. The consensus topology of GtrIV.
Additional file 4: Figure S3. Representative computer-based topology
predictions of GtrIV.
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